Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo (Q35982135)

11 August 2017

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo (English)

1 reference

11 August 2017

0 references

Jones AL

1

1 reference

11 August 2017

Millar JL

2

1 reference

11 August 2017

Millar BC

3

1 reference

11 August 2017

Powell B

4

1 reference

11 August 2017

Selby P

5

1 reference

11 August 2017

Winkley A

6

1 reference

11 August 2017

Lakhani S

7

1 reference

11 August 2017

Gore ME

8

1 reference

11 August 2017

McElwain TJ

9

1 reference

11 August 2017

1 November 1990

1 reference

British Journal of Cancer

11 August 2017

language of work or name

English

0 references

published in

1 reference

11 August 2017

62

1 reference

11 August 2017

5

1 reference

11 August 2017

776-780

1 reference

Three consecutive phase II studies of recombinant interferon alfa-2a in advanced malignant melanoma. Updated analyses

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Tumour necrosis factor in man: clinical and biological observations

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

An endotoxin-induced serum factor that causes necrosis of tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

DTIC (NSC-45388) in malignant melanoma: a perspective

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Nitrosoureas in the management of disseminated malignant melanoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971510

Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons

27 July 2018

1 reference

12 December 2020

Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines

1 reference

12 December 2020

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor

1 reference

12 December 2020

Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts

1 reference

12 December 2020

The therapeutic response of three human tumor lines maintained in immune-suppressed mice

1 reference

12 December 2020

Effect of tumour necrosis factor on cultured human melanoma cells

1 reference

12 December 2020

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.378

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

2245169

1 reference